Abstract
Background: Inflammation plays a central role in the pathophysiology of heart failure (HF) with preserved ejection fraction (HFpEF). The neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) are novel inflammatory markers which have been shown to predict post-discharge outcome in patients with HF. However, there is no information available on the combined usefulness of NLR and PLR in patients with HFpEF who are admitted with acute decompensated heart failure (ADHF). Methods: Patients' data were extracted from The Prospective mUlticenteR obServational stUdy of patIenTs with Heart Failure with Preserved Ejection Fraction (PURSUIT-HFpEF), which is a prospective multicenter observational registry for ADHF patients with LVEF ≥50% in Osaka area. We studied 1011 patients who survived to discharge. NLR and PLR were measured at the time of admission. The NLR was calculated as the ratio of the neutrophil count to the lymphocyte count, and the PLR was calculated as the ratio of the platelet count to the lymphocyte count. The endpoint was cardiac death (CD). Results: During a follow-up period of 539±423 days, 81 patients had CD. Both NLR and PLR were significantly higher in the patients with than without CD. The optimal cut-off values of NLR and PLR were 4.5 and 193 on receiver operating characteristic curve analysis, respectively. At multivariate Cox analysis, higher NLR (hazard ratio [HR] 2.51, 95% confidence interval [CI] 1.49-4.22, p=0.0006) or higher PLR (HR 1.91, 95% CI 1.15-3.19, p=0.0130) were independently associated with CD. Moreover, the combination of higher NLR and higher PNR was the strongest predictor of CD (HR 2.84, 95% CI 1.56-5.17, p=0.0007). There was significant difference in the rate of CD among the three groups stratified by NLR and PLR values. Conclusions: In this multicenter study, the combination of NLR and PLR was shown to be a useful marker for the prediction of post-discharge outcome in patients with HFpEF admitted for ADHF.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.